Showing 2661-2670 of 9399 results for "".
Skin Cancer Removal Demonstration
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/skin-cancer-removal-demonstration/19417/In a good portion of DermTV episodes, Dr. Schultz discusses the importance of sun protection. As if you didn't need another reason, in this episode of DermTV, Dr. Schultz actually brings you into the operating room and shows you an actual skin cancer removal.Hyaluronic Acid as Filler and Moisturizer
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/hyaluronic-acid-as-filler-and-moisturizer/19420/Most people are common with hyaluronic acid being used as a filler to remove lines and wrinkles. However, it also serves as a great moisturizer when applied topically in the proper form. In this episode of DermTV, Dr. Schultz shares everything you need to know about hyaluronic acid.Evaluating Roflumilast for Seborrheic Dermatitis
https://practicaldermatology.com/videos/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/Practical Dermatology Editorial Board member Raj Chovatiya, MD, PhD, MSCI, discusses results from the Phase 3 STRATUM trial studying the efficacy of roflumilast for the treatment of seborrheic dermatitis in patients with diverse skin types.FDA Grants Interchangeability to HADLIMA
https://practicaldermatology.com/videos/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.I Came In Like a Wrecking Ball
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/i-came-in-like-a-wrecking-ball/33162/I have to start by warning you, dear reader, that I am writing my first editorial for Practical Dermatology immediately after typing up four appeal letters to insurance companies.Breakthroughs in Alopecia Areata Treatment
https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/breakthroughs-in-alopecia-areata-treatment/33019/Adelaide A. Hebert, MD, chief of pediatric dermatology at the University of Texas Medical School in Houston, talks about her presentation at Masterclasses in Dermatology 2025 discusses breatkthrough treatments for alopecia areata in patients aged 12 and older.A Key to Successful Teen Acne Treatment
https://practicaldermatology.com/topics/acne-rosacea/Key-Successful-Teen-Acne-Treatment/32981/Acne has a significant psychological aspect that affects the quality of life of adolescents. The appearance of acne often causes feelings of shame, reduced self-esteem, anxiety, and even depression in young people. In some cases, it can lead to difficulties in social adaptation and social isolation,Acne and Rosacea: Dr. Harper
https://practicaldermatology.com/programs/practical-dermatology/acne-and-rosacea-dr-harper/32686/Julie Harper, MD, summarizes her presentation during the "Update 2025: Acne and Rosacea" session at Maui Derm 2025, which focused on spironolactone, oral contraceptives, and topical clascoterone.A New Year and New Beginnings
https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/a-new-year-and-new-beginnings/32417/The Practical Dermatology Podcast relaunches with the latest news to start 2025 and a conversation between Chief Medical Editor Neal Bhatia, MD, FAAD, and new Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD. Dr. Bhatia and Dr. Swanson discuss the new wave of atopic dermatitis therapeuticVtama Approved for AD in Adults and Children
https://practicaldermatology.com/videos/dermwire-tv/vtama-approved-ad-adults-and-children/30079/In this week's DermwireTV, the FDA approves Vtama (tapinarof cream 0.1%) for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizumab) for moderate-to-severe AD; and the president of Nuance Medical discusses the acquisition of scar treatment brand, Biocorneum.